Indoco Remedies Ltd

INDOCO Stock View

(NSE)

353.05

3,319.72
Proj. ROE (%)
19.57
Proj. P/E (x)
17.01
Proj EV / EBITDA (x)
9.17
Proj. P/BV (x)
3.02
Proj. Revenue ( Cr.)
1,771.33

Stock View

BUY
Share on
The average score for Indoco Remedies Ltd stands at 10 against 9, three months back.

Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company's geographical segments include India and Outside India. The Company has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
376.91
100 DMA ()
373.71
200 DMA ()
391.73
52 Weeks Range
322.70
517.80
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity